文献速递神经肿瘤

老年患者立体定向活检:风险评估及其对治疗决策的影响

Stereotactic biopsy in elderly patients: risk assessment and impact on treatment decision.
PubMed 文献 · J Neurooncol · 2017-06-21

该单中心回顾性分析纳入2005年1月至2015年12月间接受立体定向活检的230例≥70岁患者,评估风险、诊断率及对治疗决策的影响。病理诊断明确率为97%,手术相关死亡率为0.4%,暂时性和永久性并发症发生率分别为8.3%和3.5%;并发症与所分析参数均无关,仅术前KPS影响是否放弃疾病特异性治疗(p < 0.001)。

要点

  • 老年患者立体定向活检病理诊断明确率达97%,其中肿瘤性病变占91.7%。
  • 手术相关死亡率为0.4%,暂时性并发症发生率为8.3%,永久性并发症发生率为3.5%。
  • 并发症发生率与人口学、KPS、合并症评分及抗凝使用均无关。

核心结论

  • 老年患者立体定向活检具有有利的风险特征和高诊断率,即使在高合并症和抗凝治疗患者中也能实现基于组织的治疗决策。

研究设计与样本

  • 单中心回顾性分析,纳入2005年1月至2015年12月间接受立体定向活检的230例年龄≥70岁、影像学表现不明确的脑病变患者。

主要发现

  • 229例患者立体定向活检技术成功,中位年龄74(70-87)岁,男性占56.1%,术前中位KPS为80%(30-100)。
  • 中位CHA2DS2-VASc评分为4(1-9),29.6%的患者接受抗凝治疗,中位住院时间为8(2-29)天。
  • 病理诊断明确率为97%,肿瘤性病变占91.7%(高级别胶质瘤62.6%、淋巴瘤18.3%、转移瘤4.8%、低级别胶质瘤3.0%、其他肿瘤3.0%),非肿瘤性病变占5.3%。
  • 手术相关死亡率为0.4%,暂时性和永久性并发症分别发生于19例(8.3%)和8例(3.5%)患者。
  • 并发症发生率与上述参数均无关;171例(74.3%)患者开始辅助治疗;放弃疾病特异性治疗仅受术前KPS影响(p < 0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

To evaluate risk profile, diagnostic yield and impact on treatment decision of stereotactic biopsy (SB) in elderly patients with unclear cerebral lesions. In this single center retrospective analysis we identified all patients aged ≥70 years receiving SB between January 2005 and December 2015. Demographic data, Karnofsky Performance Status (KPS), histology, comorbidity (by CHA2DS2-VASc Score) and use of anticoagulation were retrieved. We scrutinized diagnostic yield, procedural complications (mortality, transient and permanent morbidity), hospitalization time and therapeutic consequence. For correlation analysis Chi-Square, Mann-Whitney rank sum test and binary regression were used. Two hundred and thirty patients were included. In 229 patients SB was technically successful. Median age was 74 (70-87) years, 56.1% of patients were male and median preoperative KPS was 80% (30-100). Median CHA2DS2-VASc Score was 4 (1-9), with 29.6% receiving anticoagulation. Median hospital stay was 8 (2-29) days. Pathological diagnosis was conclusive in 97% revealing neoplastic lesions in 91.7% (high-grade glioma 62.6%, lymphoma 18.3%, metastasis 4.8%, low-grade glioma 3.0% and other tumors 3.0%) and non-neoplastic lesions in 5.3% of cases. Procedure-related mortality was 0.4%, transient and permanent morbidity occurred in 19 patients (8.3%) and eight patients (3.5%). Complication rate was not associated with any of the above-mentioned parameters. Adjuvant therapy was initiated in 171 (74.3%) patients. Decision against disease-specific therapy was only influenced by preoperative KPS (p < 0.001). SB in elderly patients is characterized by a favorable risk profile and high diagnostic yield, allowing tissue based therapeutic consequences even in patients with high comorbidity and anticoagulant medication.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Kellermann SG, Hamisch CA, Rueß D, et al. Stereotactic biopsy in elderly patients: risk assessment and impact on treatment decision. J Neurooncol. 2017. PMID: 28639133. doi:10.1007/s11060-017-2522-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。